Understanding the CAGR Trends: Global Point of Care Diagnostics Market to grow at CAGR of 6.61% by 2030, Anticipates DelveInsight | Hoffmann-La Roche Ltd., BD, Danaher, Abbott, Siemens Healthcare Private Limited, Nova Biomedical, Quidel Corporation, Chemb

As per DelveInsight's assessment, the Point of Care Diagnostics Market is expected to grow at an immense pace in the coming years owing to the The increasing prevalence of pandemic such as COVID-19, Pre- and post-operation and some few of the other applications where Point of Care Diagnostics have been used, which is expected to drive the demand for Point of Care Diagnostics in the upcoming years.

DelveInsight's "Point of Care Diagnostics Market" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Point of Care Diagnostics companies actively working in the market.

Get The Detailed Global Point of Care Diagnostics Market Report:
https://www.delveinsight.com/sample-request/point-of-care-diagnostics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Point of Care Diagnostics Overview
Point of Care With the use of a range of diagnostic tests conducted nearby, usually in clinics, hospitals, and patients' homes, diagnostics are instruments that enable prompt evaluation of a patient's health.

Point of Care Diagnostics Market Insights
The need for point-of-care diagnostics will rise in tandem with the growing number of diabetic patients. The point-of-care diagnostics market will be stimulated by the increasing use of these devices by individuals to track their health status on a regular basis or to identify any potential abnormalities in their vital signs that could lead to an early diagnosis of a variety of diseases.

DelveInsight Analysis: The Global Point of Care Diagnostics market size is anticipated to grow with a CAGR of 6.61% during the forecasted period (2024-2030).

To know more about why North America is leading the market growth in the Point of Care Diagnostics market, get a snapshot of the report Point of Care Diagnostics Market Trends
https://www.delveinsight.com/report-store/point-of-care-diagnostics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Point of Care Diagnostics Market Report
• In January 2023, Cipla announced the launch of a point of care testing device named Cippoint which offers a wide range of testing parameters including cardiac markers, diabetes, infectious diseases, fertility, thyroid function, inflammation, metabolic markers, and others.
• In August 2022, Precision Diabetes, Inc. and DxGen Corp., entered into an exclusive agreement in the US to launch Epithod® AutoDx, a fully-automatic point of care (POC) analyzer that measures a comprehensive profile of diabetes tests.
• In July 2021, QuantuMDx Group Limited, a UK-based developer of transformational point of care diagnostics, announced the launch of Q-POC™ - a rapid, PCR point of care diagnostic system in the UK.

To read more about the latest highlights related to Point of Care Diagnostics, get a snapshot of the key highlights entailed in the Point of Care Diagnostics Market Forecast Report
https://www.delveinsight.com/sample-request/point-of-care-diagnostics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Key Players in the Point of Care Diagnostics Market
Some of the key market players operating in the Point of Care Diagnostics market include- F. Hoffmann-La Roche Ltd., BD, Danaher, Abbott, Siemens Healthcare Private Limited, Nova Biomedical, Quidel Corporation, Chembio Diagnostics, Inc., EKF Diagnostics Holdings plc., Trinity Biotech, Fluxergy, Thermo Fisher Scientific, Quest Diagnostics Incorporated, DiaSys Diagnostics India Pvt Ltd., Cipla, Sysmex Europe SE, Lumos Diagnostics™, Trivitron Healthcare, Getein Biotech, Inc., ACON Laboratories, Inc., and others.

COVID-19 Impact Analysis on the Point of Care Diagnostics Market
According to estimates, North America will hold the most proportion of the global point-of-care diagnostics market in 2023. The market for point of care diagnostics is anticipated to flourish in the region during the forecast period 2024-2030 due to the significance of key growth factors like the rising prevalence of infectious diseases, the rising number of cases of diabetes and other lifestyle-based diseases, high disposable income, sophisticated healthcare infrastructure, presence of key players, increasing product development activities, and others.
Additionally, The introduction of the COVID-19 infection has had a positive impact on the point-of-care diagnostics business. Despite the unexpected and catastrophic effects of the COVID-19 pandemic, the demand for point-of-care diagnostics was positively impacted because the POC diagnostic was quickly utilized to diagnose COVID-19. Rapid antigen testing kits that work well in point-of-care settings are in high demand due to the rapidly increasing number of COVID-19 cases and the mounting pressure on the government to improve patient management. So, during the projected period, the market for Point of Care Diagnostics is anticipated to continue expanding (2024-2030).

Scope of the Point of Care Diagnostics Market Report
• Coverage: Global
• Study Period: 2021-2030
• Point of Care Diagnostics Market Segmentation By Product Type: Instruments, Kits And Reagents
• Point of Care Diagnostics Market Segmentation By Application: Blood Glucose Monitoring, Infectious Diseases, Cardio-Metabolic Diseases, Pregnancy & Fertility Testing, And Others
• Point of Care Diagnostics Market Segmentation By End User: Hospitals, Diagnostic Centers, Home Care Settings, And Others
• Point of Care Diagnostics Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Point of Care Diagnostics Companies: Amgen Inc., AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, Bristol-Myers Squibb, Eli Lilly and CoF. Hoffmann-La Roche Ltd., BD, Danaher, Abbott, Siemens Healthcare Private Limited, Nova Biomedical, Quidel Corporation, Chembio Diagnostics, Inc., EKF Diagnostics Holdings plc., Trinity Biotech, Fluxergy, Thermo Fisher Scientific, Quest Diagnostics Incorporated, DiaSys Diagnostics India Pvt Ltd., Cipla, Sysmex Europe SE, Lumos Diagnostics™, Trivitron Healthcare, Getein Biotech, Inc., ACON Laboratories, Inc., and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Which MedTech key players in the Point of Care Diagnostics market are set to emerge as the trendsetter explore @ Point of Care Diagnostics Manufacturer
https://www.delveinsight.com/sample-request/point-of-care-diagnostics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1 Point of Care Diagnostics Market Report Introduction
2 Point of Care Diagnostics Market Executive summary
3 Regulatory and Patent Analysis
4 Point of Care Diagnostics Market Key Factors Analysis
5 Porter's Five Forces Analysis
6 COVID-19 Impact Analysis on Point of Care Diagnostics Market
7 Point of Care Diagnostics Market Layout
8 Global Company Share Analysis - Key 3-5 Companies
9 Company and Product Profiles
10 Point of Care Diagnostics Market Drivers
11. Point of Care Diagnostics Market Barriers
12. Project Approach
13. About DelveInsight

Interested in knowing how the Point of Care Diagnostics market will grow by 2030? Click to get a snapshot of the Point of Care Diagnostics Market Analysis
https://www.delveinsight.com/sample-request/cancer-immunotherapy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Latest Reports Offered By DelveInsight:
Herpes Simplex Virus Market
https://www.delveinsight.com/report-store/herpes-simplex-market
DelveInsight's "Herpes Simplex - Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Herpes Simplex, historical and forecasted epidemiology as well as the Herpes Simplex market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Hypercoagulability Market
https://www.delveinsight.com/report-store/hypercoagulability-market
DelveInsight's "Hypercoagulability- Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hypercoagulability, historical and forecasted epidemiology as well as the Hypercoagulability market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Idiopathic Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/idiopathic-thrombocytopenic-purpura-market
DelveInsight's "Idiopathic Thrombocytopenic Purpura Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Idiopathic Thrombocytopenic Purpura, historical and forecasted epidemiology as well as the Idiopathic Thrombocytopenic Purpura market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Inguinal Hernia Market
https://www.delveinsight.com/report-store/inguinal-hernia-market
DelveInsight's "Inguinal Hernia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Inguinal Hernia, historical and forecasted epidemiology as well as the Inguinal Hernia market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Charcot-marie-tooth Disease Market
https://www.delveinsight.com/report-store/charcot-marie-tooth-disease-market
DelveInsight's 'Charcot-Marie-Tooth Disease Market Insights, Epidemiology, and Market Forecast 2032' report deliver an in-depth understanding of the Charcot-Marie-Tooth Disease, historical and forecasted epidemiology as well as the Charcot-Marie-Tooth Disease market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.

Listeriosis Market
https://www.delveinsight.com/report-store/listeriosis-market
DelveInsight's comprehensive report titled "Listeriosis Market Insights, Epidemiology, and Market Forecast - 2034" offers a detailed analysis of Listeriosis. The report presents historical and projected epidemiological data covering incident cases of listeriosis, age-specific cases of listeriosis, gender-specific cases of listeriosis, risk-associated cases of listeriosis, and treated cases of listeriosis.

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
https://www.delveinsight.com/medical-devices

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.